If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Pre-close period trading update

2 Apr 2013 07:00

RNS Number : 2254B
First Derivatives PLC
02 April 2013
 

2 April 2013

First Derivatives plc

("First Derivatives" or "the Company")

 

Pre-Close Period Trading Update

 

First Derivatives plc (AIM: FDP.L, ESM: GYQ.I), a leading provider of software and consulting services to the capital markets industry, has today announced that trading in the second six months of the financial year ended 28 February 2013 is expected to be broadly in line with that achieved in the first half.

 

The Company announced a significant new contract in December 2012 which is currently being delivered. The Company has committed significant resource to the successful implementation of this contract which is progressing well. Despite this, the current timing of the delivery means that the Company does not expect to recognise the majority of the implementation revenue from this contract in the year to 28 February 2013 and that license revenue recognition will not start until after the year end.

 

The Company also announces that a disputed debt has arisen from a legacy delivery from the business of Cognotec, which was acquired in February 2010. The Company is robustly pursuing the contracted payments due, but believes that a significant provision against this debtor in the accounts for the year to 28 February 2013 is prudent at this time. There are no other legacy issues surrounding the business of Cognotec.

 

The Board confirms that results for the year to 28 February 2013, prior to the non-recurring debt provision referred to above, are expected to be in line or close to current market forecasts.

 

Prospects for the business remain positive and the Company has made a strong start to the new financial year. Further details will be published when the Company reports its results for the year to 28 February 2013, which will be announced on Tuesday 18 June 2013.

 

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive

www.firstderivatives.com

Graham Ferguson, Chief Financial Officer

Charles Stanley Securities(Nominated Adviser)

+44 (0)20 7149 6000

Russell Cook

Carl Holmes

Goodbody Corporate Finance(ESM Adviser)

+353 1 667 0420

Diane Hodgson

Linda Hickey

Walbrook PR

+44 (0)20 7933 8780

Bob Huxford

bob.huxford@walbrookpr.com

Paul Cornelius

paul.cornelius@walbrookir.com

 

 

About First Derivatives

 

First Derivatives is a global provider of software and consulting services to the financial services industry. With over 15 years experience working with leading financial institutions, it continues to deliver technologically advanced, award winning products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 710 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTWGUBWWUPWGQU
Date   Source Headline
9th May 20257:00 amRNSForm 8.3 - FD Technologies plc
8th May 20253:26 pmRNSForm 8.3 - FD Technologies PLC
8th May 20253:22 pmPRNForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20252:49 pmRNSForm 8.3 FD TECHNOLOGIES PLC
8th May 20251:51 pmRNSForm 8.3 - FD TECHNOLOGIES PLC
8th May 202511:24 amRNSForm 8.3 - FD Technologies PLC
8th May 202511:13 amRNSForm 8.5 (EPT/RI) - FD Technologies plc
8th May 202510:02 amRNSForm 8.5 (EPT/NON-RI) FD Technologies plc
8th May 20259:53 amGNWForm 8.5 (EPT/RI) - FD Technologies Plc
8th May 20257:00 amRNSRECOMMENDED ACQUISITION OF FD TECHNOLOGIES PLC
7th May 202511:26 amRNSStatement regarding Possible Offer
16th Apr 20257:44 amRNSHolding(s) in Company
11th Apr 20251:25 pmRNSIssue of Equity
2nd Apr 20258:49 amRNSIssue of Equity
25th Mar 20257:00 amRNSTrading Statement
7th Mar 20259:24 amRNSHolding(s) in Company
4th Feb 20253:57 pmRNSIssue of Equity
4th Feb 20252:45 pmRNSHolding(s) in Company
3rd Feb 20252:36 pmRNSHolding(s) in Company
3rd Feb 202510:19 amRNSHolding(s) in Company
31st Jan 20254:01 pmRNSHolding(s) in Company
30th Jan 20252:09 pmRNSHolding(s) in Company
24th Jan 20257:00 amRNSTENDER OFFER RESULTS AND TOTAL VOTING RIGHTS
20th Jan 20257:00 amRNSHolding(s) in Company
15th Jan 20252:20 pmRNSRESULTS OF GENERAL MEETING
8th Jan 20251:36 pmRNSHolding(s) in Company
8th Jan 20257:00 amRNSIssue of Equity
19th Dec 20245:00 pmRNSPublication of Circular Notice of GM
19th Dec 20247:00 amRNSProposed Tender Offer
13th Dec 20244:54 pmRNSIssue of Equity
13th Dec 20247:00 amRNSNotification of Long-Term Incentive Award to PDMR
3rd Dec 20247:00 amRNSCOMPLETION OF DIVESTMENT OF FIRST DERIVATIVE
26th Nov 20247:00 amRNSInterim Results
14th Nov 20247:00 amRNSProposed Divestment - Satisfaction of Conditions
11th Nov 20244:22 pmRNSNotice of Results
7th Nov 20248:54 amRNSHolding(s) in Company
24th Oct 202412:37 pmRNSResult of General Meeting
8th Oct 20245:00 pmRNSPublication of Circular and Notice of GM
8th Oct 20242:35 pmRNSHolding(s) in Company
7th Oct 20247:00 amRNSProposed Divestment
5th Sep 20242:39 pmRNSHolding(s) in Company
1st Aug 20248:43 amRNSTotal Voting Rights
18th Jul 20244:45 pmRNSResult of AGM
9th Jul 20241:56 pmRNSHolding(s) in Company
4th Jul 202410:36 amRNSHolding(s) in Company
2nd Jul 20244:30 pmRNSIssue of Equity
2nd Jul 20242:17 pmRNSHolding(s) in Company
1st Jul 20245:39 pmRNSPDMR Notice and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.